Fig. 1 · Structure
Documents & Downloads
BML-111
Lipoxin A4 Receptor Agonist
BML-111 is a lipoxin A4 receptor agonist, functioning primarily by engaging the lipoxin A4 pathway. It demonstrates significant biological activities, including the repression of angiotensin-converting enzyme (ACE) and the enhancement of angiotensin-converting enzyme 2 (ACE2) activity. This compound exhibits notable antiangiogenic, antitumor, and anti-inflammatory properties, making it valuable for research in inflammatory diseases, cancer therapy, and vascular biology.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Agonist |
| CAS Number | 78606-80-1 |
| Applications | Lipoxin A4 Receptor Agonist |
| Formula | C8H16O5 |
| Molecular Weight | 192.21 |
| SMILES | O=C(OC)CCC[C@H](O)[C@H](O)CO |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.